Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Open accessAbstract
Aims/hypothesisAldosterone concentrations increase in obesity and predict the onset of diabetes. We investigated the effects of aldosterone on glucose homeostasis and insulin secretion in vivo and in vitro.MethodsWe assessed insulin sensitivity and insulin secretion in aldosterone synthase-deficient (As [also known as Cyp11b2]−/−) and wild-type mice using euglycaemic–hyperinsulinaemic and hyperglycaemic clamps, respectively. We also conducted studies during high sodium intake to normalise renin activity and potassium concentration in As−/− mice. We subsequently assessed the effect of aldosterone on insulin secretion in vitro in the presence or absence of mineralocorticoid receptor antagonists in isolated C57BL/6J islets and in the MIN6 beta cell line.ResultsFasting glucose concentrations were reduced in As−/− mice compared with wild-type. During hyperglycaemic clamps, insulin and C-peptide concentrations increased to a greater extent in As−/− than in wild-type mice. This was not attributable to differences in potassium or angiotensin II, as glucose-stimulated insulin secretion was enhanced in As−/− mice even during high sodium intake. There was no difference in insulin sensitivity between As−/− and wild-type mice in euglycaemic–hyperinsulinaemic clamp studies. In islet and MIN6 beta cell studies, aldosterone inhibited glucose- and isobutylmethylxanthine-stimulated insulin secretion, an effect that was not blocked by mineralocorticoid receptor antagonism, but was prevented by the superoxide dismutase mimetic tempol.Conclusions/interpretationWe demonstrated that aldosterone deficiency or excess modulates insulin secretion in vivo and in vitro via reactive oxygen species and in a manner that is independent of mineralocorticoid receptors. These findings provide insight into the mechanism of glucose intolerance in conditions of relative aldosterone excess.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Aldosterone directly reduces insulin secretion in isolated murine pancreatic islets.
“We recently demonstrated that aldosterone directly impairs insulin secretion in isolated murine pancreatic islets”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
Genetic aldosterone deficiency markedly increases insulin secretion in mice.
“genetic aldosterone deficiency markedly increases insulin secretion in mice (6, 7)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
Aldosterone deficiency in mice increases insulin secretion in vivo without altering insulin sensitivity.
“aldosterone deficiency in mice increases insulin secretion in vivo without altering insulin sensitivity (6).”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
Aldosterone impairs insulin secretion in isolated rodent islets and insulinoma cell lines.
“Aldosterone impairs insulin secretion in isolated rodent islets and insulinoma cell lines”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · see citing works
Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., Oka, Y., & Yamamura, K. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,267 · see citing works
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737 · see citing works
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660 · see citing works
Tuck, M. L., Sowers, J. R., Dornfeld, L., Kledzik, G. S., & Maxwell, M. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104163041602 · Cited by 643 · see citing works
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R., Stier, C. T., Kifor, I., Ochoa-Maya, M. R., Rennke, H. G., Williams, G. H., & Adler, G. K. (2000) · Endocrinology · doi:10.1210/endo.141.10.7711 · Cited by 475 · see citing works
McMurray, J. J. V. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0909392 · Cited by 450 · see citing works
Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse
Ayala, J. E., Bracy, D. P., McGuinness, O. P., & Wasserman, D. H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0686 · Cited by 399 · see citing works
Self-citationReduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
Briššová, M., Shiota, M., Nicholson, W. E., GANNON, M. A., Knobel, S. M., Piston, D. W., Wright, C. V. E., & Powers, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111272200 · Cited by 376 · see citing works
Self-citationAldosterone: effects on the kidney and cardiovascular system
Briet, M. B., & Schiffrin, E. L. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.30 · Cited by 337 · see citing works
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337 · see citing works
Hypertension, the Potassium Ion and Impaired Carbohydrate Tolerance
Conn, J. W. (1965) · New England Journal of Medicine · doi:10.1056/nejm196511182732106 · Cited by 329 · see citing works
Oxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315 · see citing works
Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats
Carlsson, P., Berne, C., & Jansson, L. E. (1998) · Diabetologia · doi:10.1007/s001250050880 · Cited by 305 · see citing works
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
Scheen, A. J. (2004) · Drugs · doi:10.2165/00003495-200464220-00004 · Cited by 293 · see citing works
Glucose Metabolism In Vivo in Four Commonly Used Inbred Mouse Strains
Berglund, E. D., Li, C. Y., Poffenberger, G., Ayala, J. E., Fueger, P. T., Willis, S. E., Jewell, M. M., Powers, A. C., & Wasserman, D. H. (2008) · Diabetes · doi:10.2337/db07-1615 · Cited by 265 · see citing works
Self-citationInsulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262 · see citing works
Plasma aldosterone is independently associated with the metabolic syndrome
Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000231338.41548.fc · Cited by 226 · see citing works
Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion
Goodfriend, T. L., Ball, D. L., Egan, B. M., Campbell, W. B., & Nithipatikom, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000113294.06704.64 · Cited by 205 · see citing works
Aldosterone Synthase Inhibition With LCI699
Amar, L., Azizi, M., Ménard, J., Peyrard, S., Watson, C. E., & Plouin, P. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 204 · see citing works
Ingelsson, E., Pencina, M. J., Tofler, G. H., Benjamin, E. J., Lanier, K. J., Jacques, P. F., Fox, C. S., Meigs, J. B., Levy, D. A., Larson, M. G., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.708537 · Cited by 195 · see citing works
The evolution of aldosterone antagonists
Garthwaite, S. M., & McMahon, E. G. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.005 · Cited by 189 · see citing works
Development of a Panel of Monoclonal Antibodies against the Mineralocorticoid Receptor
Gómez-Sánchez, C. E., de Rodriguez, A. F., Romero, D. G., Estess, J., Warden, M. P., Gomez-Sanchez, M. T., & Gómez-Sánchez, E. P. (2005) · Endocrinology · doi:10.1210/en.2005-0860 · Cited by 182 · see citing works
Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000071081.35693.9a · Cited by 158 · see citing works
Self-citationColussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155 · see citing works
Hitomi, H., Kiyomoto, H., Nishiyama, A., Hara, T., Moriwaki, K., Kaifu, K., Ihara, G., Fujita, Y., Ugawa, T., & Kohno, M. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.093955 · Cited by 140 · see citing works
β-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes
Festa, A., Williams, K., Hanley, A. J., & Haffner, S. M. (2008) · Diabetes · doi:10.2337/db07-0954 · Cited by 127 · see citing works
Lastra, G., Whaley-Connell, A., Manrique, C., Habibi, J., Gutweiler, A. A., Appesh, L., Hayden, M. R., Wei, Y., Ferrario, C., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2007 · Cited by 119 · see citing works
Effects of eplerenone versus losartan in patients with low-renin hypertension
Weinberger, M. H., White, W. B., Ruilope, L. M., MacDonald, T. M., Davidson, R. C., Roniker, B., Patrick, J. L., & Krause, S. L. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.005 · Cited by 115 · see citing works
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80020-9 · Cited by 107 · see citing works
Expression and localization of the renin-angiotensin system in the rat pancreas
Leung, P. S., Chan, W., Wong, T. P., & Sernia, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600013 · Cited by 99 · see citing works
Homeostatic Responses in the Adrenal Cortex to the Absence of Aldosterone in Mice
Lee, G., Makhanova, N., Caron, K. M., Sequeira-Lόpez, M. L. S., Gómez, R. A., Smithies, O., & Kim, H. (2005) · Endocrinology · doi:10.1210/en.2004-1102 · Cited by 95 · see citing works
Self-citationA possible association between primary aldosteronism and a lower β-cell function
Mosso, L. M., Carvajal, C. A., Maiz, A., Ortiz, E. H., Castillo, C. R., Artigas, R. A., & Fardella, C. E. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fa4 · Cited by 94 · see citing works
Lemarié, C. A., Simeone, S. M. C., Nikonova, A. S., Ebrahimian, T., Deschênes, M.-E., Coffman, T. M., Paradis, P., & Schiffrin, E. L. (2009) · Circulation Research · doi:10.1161/circresaha.109.196576 · Cited by 89 · see citing works
Hirasawa, G., Sasano, H., Takahashi, K.-I., Fukushima, K., Suzuki, T., Hiwatashi, N., Toyota, T., Krozowski, Z. S., & Nagura, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4337 · Cited by 85 · see citing works
Swaminathan, K., Davies, J. I., Casella, G., Rajendra, N. S., Morris, A. D., & Struthers, A. D. (2008) · Diabetologia · doi:10.1007/s00125-008-0972-5 · Cited by 79 · see citing works
Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?
Gekle, M., & Großmann, C. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0616-0 · Cited by 77 · see citing works
Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment
Šindelka, G., Widimsky, J., Jr., Haas, T., Prázný, M., Hilgertová, J., & Škrha, J. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1329211 · Cited by 74 · see citing works
Kidney function in mice lacking aldosterone
Makhanova, N., Lee, G., Takahashi, N., Sequeira-Lόpez, M. L. S., Gómez, R. A., Kim, H., & Smithies, O. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00257.2005 · Cited by 71 · see citing works
Self-citationEffect of adrenal steroids on insulin release from cultured rat islets of Langerhans
Pierluissi, J., Navas, F. O., & Ashcroft, S. J. H. (1986) · Diabetologia · doi:10.1007/bf00456122 · Cited by 66 · see citing works
Research Resource: Nuclear Hormone Receptor Expression in the Endocrine Pancreas
Chuang, J.-C., Cha, J.-Y., Garmey, J. C., Mirmira, R. G., & J., J. J. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0568 · Cited by 60 · see citing works
Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?
Shimamoto, K., Shiiki, M., Ise, T., Miyazaki, Y., Higashiura, K., Fukuoka, M., Hirata, A., Masuda, A., Nakagawa, M., & Iimura, O. (1994) · PubMed · Cited by 50 · see citing works
Does the treatment of primary hyperaldosteronism influence glucose tolerance?
Štrauch, B., Widimsky, J., Jr., Šindelka, G., & Škrha, J. (2003) · Physiological Research · doi:10.33549/physiolres.930298 · Cited by 44 · see citing works
Fueger, P. T., Hess, H. S., Bracy, D. P., Pencek, R., Posey, K. A., Charron, M. J., & Wasserman, D. H. (2004) · Endocrinology · doi:10.1210/en.2004-0465 · Cited by 41 · see citing works
Self-citationNon-genomic actions of aldosterone: mechanisms and consequences in kidney cells
Boldyreff, B. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg265 · Cited by 37 · see citing works
Energy Metabolism in Human Renin-Gene Transgenic Rats
Gratze, P., Boschmann, M., Dechend, R., Qadri, F., Malchow, J., Graeske, S., Engeli, S., Janke, J., Springer, J., Contrepas, A., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.124966 · Cited by 33 · see citing works
Rapid effects of aldosterone on vascular cells: clinical implications
Lösel, R. (2004) · Steroids · doi:10.1016/j.steroids.2004.05.005 · Cited by 29 · see citing works
Hirasawa, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3859 · Cited by 25 · see citing works
Luther, J. M., Wang, Z., Ma, J., Makhanova, N., Kim, H., & Brown, N. J. (2008) · Endocrinology · doi:10.1210/en.2008-1296 · Cited by 21 · see citing works
Self-citationLate-onset obesity in mice transgenic for the human renin gene
Uehara, S., Tsuchida, M., Kanno, T., Sasaki, M., Nishikibe, M., & Fukamizu, A. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.6.723 · Cited by 20 · see citing works
Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., et al. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21572 · Cited by 8 · see citing works
Successful treatment of renovascular hypertension has no effect on insulin sensitivity
Voiculescu, A., Hollenbeck, M., Kutkuhn, B., Grabensee, B., & Plum, J. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01236.x · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Jaisser, F., & Farman, N. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 332 · see citing works
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
UNDERWOOD, P. C., & Adler, G. K. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0323-2 · Cited by 214 · see citing works
Zhou, M.-S., Schulman, I. H., & Zeng, Q. (2012) · Vascular Medicine · doi:10.1177/1358863x12450094 · Cited by 207 · see citing works
The renin–angiotensin–aldosterone system and glucose homeostasis
Luther, J. M., & Brown, N. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.07.006 · Cited by 185 · see citing works
Self-citationHanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155 · see citing works
Effects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114 · see citing works
Self-citationModulation of glucose metabolism by the renin-angiotensin-aldosterone system
Favre, G. A., Esnault, V. L. M., & Van Obberghen, E. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2014 · Cited by 114 · see citing works
Extrarenal effects of aldosterone
Cat, A. N. D., & Jaisser, F. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32834fb25b · Cited by 102 · see citing works
Pasquarelli-do-Nascimento, G., Braz-de-Melo, H. A., Faria, S. S., Santos, I. D. O., Kobinger, G., & Magalhães, K. G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00530 · Cited by 99 · see citing works
Raheja, P., Price, A. L., Wang, Z., Arbique, D., ADAMS-HUET, B. A., Auchus, R. J., & Vongpatanasin, W. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.194787 · Cited by 100 · see citing works
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88 · see citing works
Circulating Aldosterone and Natriuretic Peptides in the General Community
Buglioni, A., Cannone, V., Cataliotti, A., Sangaralingham, S. J., Heublein, D. M., Scott, C. G., Bailey, K. R., Rodeheffer, R. J., Dessı̀-Fulgheri, P., Sarzani, R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03936 · Cited by 85 · see citing works
Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
Lefranc, C., Friederich‐Persson, M., Palacios, R., & Cat, A. N. D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0163 · Cited by 79 · see citing works
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism
Ohno, Y., Sone, M., Inagaki, N., Yamasaki, T., Ogawa, O., Takeda, Y., Kurihara, I., Umakoshi, H., Ichijo, T., Katabami, T., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00866 · Cited by 75 · see citing works
Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans
Adler, G. K., Murray, G. R., Turcu, A. F., Nian, H., Yu, C., Solorzano, C. C., Manning, R., Peng, D., & Luther, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13922 · Cited by 71 · see citing works
“We recently demonstrated that aldosterone directly impairs insulin secretion in isolated murine pancreatic islets and that genetic aldosterone deficiency markedly increases insulin secretion in mice.(6,7) Similarly, short-term stimulation of the renin-angiotensin-aldosterone system during sodium restriction impairs in…”
BackgroundResultSelf-citationMartinerie, L., Munier, M., Menuet, D. L., Méduri, G., Viengchareun, S., & Lombès, M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.09.030 · Cited by 67 · see citing works
Wu, T., Shao, Y., Li, X., Wu, T., Yu, L. K., Liang, J. H., Zhang, Y., Wang, J., Sun, T., Zhu, Y., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2200625 · Cited by 64 · see citing works
Savarese, G., Lindberg, F., Filippatos, G. S., Butler, J., & Anker, S. D. (2023) · Diabetologia · doi:10.1007/s00125-023-06031-1 · Cited by 64 · see citing works
Aldosterone Production and Signaling Dysregulation in Obesity
Vecchiola, A., Lagos, C. F., Carvajal, C. A., Baudrand, R. F., & Fardella, C. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0626-9 · Cited by 61 · see citing works
Central regulation of blood pressure by the mineralocorticoid receptor
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.005 · Cited by 58 · see citing works
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 53 · see citing works
Lastra, G., & Sowers, J. R. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0025 · Cited by 54 · see citing works
Gangadhariah, M. H., Dieckmann, B. W., Lantier, L., Kang, L., Wasserman, D. H., Chiusa, M., Caskey, C. F., Dickerson, J., Luo, P., Gamboa, J. L., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4260-0 · Cited by 54 · see citing works
Self-citationMetabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
Kalra, S., Unnikrishnan, A., Baruah, M. P., Sahay, R. K., & Bantwal, G. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286888 · Cited by 54 · see citing works
The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease
Wu, Q., Burley, G., Li, L., Lin, S., & Shi, Y. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14980 · Cited by 57 · see citing works
Garg, R., Kneen, L., Williams, G. H., & Adler, G. K. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12224 · Cited by 50 · see citing works
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 46 · see citing works
Jia, G., Lockette, W. E., & Sowers, J. R. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00280.2020 · Cited by 45 · see citing works
Hu, Y., Zhang, J., Liu, W., & Su, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz293 · Cited by 42 · see citing works
Luo, P., Dematteo, A., Wang, Z., Zhu, L., Wang, A., Kim, H.-S., Pozzi, A., Stafford, J. M., & Luther, J. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2814-8 · Cited by 41 · see citing works
Self-citationJin, H. M., Zhou, D. C., Gu, H. F., Qiao, Q. Y., Fu, S. K., Liu, X. L., & Pan, Y. (2013) · Endocrinology · doi:10.1210/en.2013-1115 · Cited by 41 · see citing works
The mineralocorticoid receptor—an emerging player in metabolic syndrome?
Thuzar, M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00467-3 · Cited by 38 · see citing works
Tsurutani, Y., Sugisawa, C., Ishida, A., Inoue, K., Saito, J., Omura, M., Nagasaka, S., & Nishikawa, T. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej16-0500 · Cited by 32 · see citing works
Aldosterone induces clonal β-cell failure through glucocorticoid receptor
Chen, F., Liu, J., Wang, Y., Wu, T., Shan, W., Zhu, Y., & Han, X. (2015) · Scientific Reports · doi:10.1038/srep13215 · Cited by 31 · see citing works
Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury
Fouad, A. A., Al-Mulhim, A. S., Jresat, I., & Morsy, M. A. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01585.x · Cited by 30 · see citing works
Glucose Metabolism in Primary Aldosteronism
Remde, H., Hanslik, G., Rayes, N., & Quinkler, M. O. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565208 · Cited by 30 · see citing works
Targeting the renin angiotensin system for the treatment of anxiety and depression
Chrissobolis, S., Luu, A. N., Waldschmidt, R. A., Yoakum, M. E., & D’Souza, M. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173063 · Cited by 30 · see citing works
Role of mineralocorticoid receptor in insulin resistance
Garg, R., & Adler, G. K. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283533955 · Cited by 30 · see citing works
Johansen, M. L., Schou, M., Rossignol, P., Holm, M. R., Rasmussen, J., Brandt, N., Frandsen, M. N., Chabanova, E., Dela, F., Faber, J. O., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13809 · Cited by 29 · see citing works
Secondary diabetes mellitus due to primary aldosteronism
Moustaki, M., Paschou, S. Α., Vakali, E., & Vryonidou, A. (2022) · Endocrine · doi:10.1007/s12020-022-03168-8 · Cited by 28 · see citing works
Luther, J. M., Byrne, L. M., Yu, C., Wang, T. J., & Brown, N. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2122 · Cited by 26 · see citing works
Self-citationSato, A. (2015) · Hypertension Research · doi:10.1038/hr.2015.19 · Cited by 26 · see citing works
Inhibitors of Aldosterone Synthase
Weldon, S. M., & Brown, N. F. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.002 · Cited by 26 · see citing works
Self-citationAldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders
Garg, R., & Adler, G. K. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0567-8 · Cited by 26 · see citing works
Spyroglou, A., Handgriff, L., Müller, L., Schwarzlmueller, P., Parasiliti‐Caprino, M., Fuß, C. T., Remde, H., Hirsch, A., O’Toole, S. M., Thuzar, M., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0040 · Cited by 22 · see citing works
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20 · see citing works
Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population
Chen, Y., Chen, X., Chen, Q., & Yu, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.565714 · Cited by 20 · see citing works
Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats
Hofmann, A., Brunßen, C., Peitzsch, M., Martin, M., Mittag, J., Jannasch, A., Engelmann, F., Brown, N. F., Weldon, S. M., Huber, J., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1358 · Cited by 20 · see citing works
Self-citationMineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction
Igbekele, A. E., Jia, G., Hill, M. A., Sowers, J. R., & Jia, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168954 · Cited by 19 · see citing works
Yang, P., Huang, T., & Xu, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.06.001 · Cited by 19 · see citing works
Effects of Primary Aldosteronism and Different Therapeutic Modalities on Glucose Metabolism
Kwak, M. K., Lee, J. Y., Kim, B., Lee, S. H., & Koh, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122194 · Cited by 19 · see citing works
Okazaki‐Hada, M., Moriya, A., Nagao, M., Oikawa, S., Fukuda, I., & Sugihara, H. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13312 · Cited by 18 · see citing works
Mineralocorticoid receptors in non‐alcoholic fatty liver disease
Schreier, B., Zipprich, A., Uhlenhaut, N. H., & Gekle, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15784 · Cited by 17 · see citing works
D’Elia, J. A., Segal, A. R., Bayliss, G. P., & Weinrauch, L. A. (2017) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s135899 · Cited by 17 · see citing works
Liao, W.-H., Suendermann, C., Steuer, A. E., Pacheco Lopez, G., Odermatt, A., Faresse, N., Henneberg, M., & Langhans, W. (2018) · JCI Insight · doi:10.1172/jci.insight.99015 · Cited by 16 · see citing works
Insulin Sensitization Therapy and the Heart
Wong, A., Struthers, A. D., Choy, A. M., & Lang, C. C. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.002 · Cited by 16 · see citing works
de Oliveira, C. A. R., Araújo, T. R., Aguiar, G. D. S., da Silva, J. A., Vettorazzi, J. F., Freitas, I. N., de Oliveira, K. M., Boschero, A. C., Bonfleur, M. L., Clarke, J. R., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.03.018 · Cited by 15 · see citing works
Manosroi, W., Atthakomol, P., Watanawittawas, P., & Buranapin, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.870047 · Cited by 14 · see citing works
Pancreatic functions in high salt fed female rats
Lasheen, N. N. (2015) · Physiological Reports · doi:10.14814/phy2.12443 · Cited by 14 · see citing works
Lee, K. J., Lee, S. Y., & Ji, G. E. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2583 · Cited by 13 · see citing works
Komada, H., Hirota, Y., So, A., Nakamura, T., Okuno, Y., Fukuoka, H., Iguchi, G., Takahashi, Y., Sakaguchi, K., & Ogawa, W. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.10.002 · Cited by 14 · see citing works
Neurohormonal regulation of pancreatic secretion
Chandra, R., & Liddle, R. A. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283567f16 · Cited by 13 · see citing works
Bell, R. M. B., Villalobos, E., Nixon, M., Miguelez-Crespo, A., Murphy, L., Fawkes, A., Coutts, A. A., Sharp, M. G. F., Koerner, M. V., Allan, E., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101225 · Cited by 12 · see citing works
Liu, G.-Z., Zhang, S., Li, Y., Liu, Y., Zhang, Y., Xin-bo, Z., Yuan, Y., Zhang, J.-W., Khannanova, Z., & Li, Y. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01641-2 · Cited by 12 · see citing works
Cloro, C., Zaffina, I., Sacchetta, L., Arturi, F., Clausi, C., Lucà, S., Pelle, M. C., Giofrè, F., Armentaro, G., Forte, V., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.940654 · Cited by 12 · see citing works
Wang, J., Hu, H., Song, J., Yan, F., Qin, J., Guo, X., Cui, C., He, Q., Hou, X., Liu, F., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.149 · Cited by 11 · see citing works
Vascular Dysfunction and Insulin Resistance in Aging
Baranowska-Bik, A., & Bik, W. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161117666181129113611 · Cited by 11 · see citing works
Shimada, H., Kogure, N., Noro, E., Kudo, M., Sugawara, K., Sato, I., Shimizu, K., Kobayashi, M., Suzuki, D., Parvin, R., et al. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12277 · Cited by 10 · see citing works
Pralle, R. S., Schultz, N. E., White, H. M., & WEIGEL, K. A. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00016.2020 · Cited by 10 · see citing works
Then, C., Ritzel, K., Herder, C., Then, H. L., Sujana, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002558 · Cited by 9 · see citing works
The mineralocorticoid receptor: a new player controlling energy homeostasis
Kuhn, E., & Lombès, M. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0033 · Cited by 9 · see citing works
Goto, R., Kondo, T., Ono, K., Kitano, S., Miyakawa, N., Watanabe, T., Sakaguchi, M., Sato, M., Igata, M., Kawashima, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050674 · Cited by 8 · see citing works
Assessment and Management of Primary Aldosteronism in Pregnancy: A Case–Control Study
Downie, E., Shanmugalingam, R., Hennessy, A., & Makris, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac311 · Cited by 8 · see citing works
Greco, E. A., Feraco, A., Marzolla, V., Mirabelli, M., Cimino, L., Armani, A., Brunetti, A., & Caprio, M. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.07.010 · Cited by 8 · see citing works
Pillai, K. V., Fares, A., Dargham, S. R., Suwaidi, J. M. S. A., Jayyousi, A., & Khalil, C. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1147225 · Cited by 6 · see citing works
Товчига, О. В. (2014) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2014/7201 · Cited by 6 · see citing works
Fonseca, P. A. D. S., Suárez‐Vega, A., Esteban‐Blanco, C., Marina, H., Pelayo, R., Gutiérrez‐Gil, B., & Arranz, J.-J. (2025) · BMC Genomics · doi:10.1186/s12864-025-11520-1 · Cited by 6 · see citing works
The mineralocorticoid system, cardiometabolic health and its interplay with adipose tissue
Thuzar, M., Halim, M. A., & Stowasser, M. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0119 · Cited by 5 · see citing works
Mineralocorticoids, glucose homeostasis and type 2 diabetes mellitus: The Henan Rural Cohort study
Wei, D., Liu, X., Jiang, J., Tu, R., Qiao, D., Li, R., Wang, Y., Fan, M., Yang, X., Zhang, J., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107558 · Cited by 5 · see citing works
Glucocorticoids reduce Slc2a2 ( GLUT2 ) gene expression through HNF1 in pancreatic β-cells
Ono, Y., & Kataoka, K. (2024) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0077 · Cited by 4 · see citing works
Barrea, L., Caprio, M., Perrini, S., Camajani, E., Crafa, A., Gangitano, E., Gorini, S., Sciacca, L., Verde, L., Albertelli, M., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02589-2 · Cited by 4 · see citing works
Role of Aldosterone in Insulin Resistance: Fact of Fantasy
Sechi, L. A., & Colussi, G. (2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000161 · Cited by 4 · see citing works
Eplerenone–A novel Mineralocorticoid receptor antagonist for the clinical application
Wu, N., Zhang, Y.-Y., & Zhao, D. (2022) · Environmental Disease · doi:10.4103/ed.ed_7_21 · Cited by 4 · see citing works
Leukocyte metabolism in obese type 2 diabetic individuals associated with COVID-19 severity
Lobato, T. B., Gennari-Felipe, M., Pauferro, J. R. B., Correa, I. S., Santos, B. F., Dias, B. B., Borges, J. C. D. O., dos Santos, C. S., Santos, E. S. D. S., de Araújo, M. J. L., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1037469 · Cited by 4 · see citing works
Zhou, S., Liu, J., Li, Z., Yang, M., Sha, R., Yan, R., Wang, X., & Cao, Y. (2024) · Hypertension Research · doi:10.1038/s41440-024-01648-0 · Cited by 4 · see citing works
Eight weeks of mineralocorticoid blockade does not improve insulin sensitivity in type 2 diabetes
Finsen, S. H., Hansen, M. R., Hoffmann‐Petersen, J., Højgaard, H. F., & Mortensen, S. P. (2021) · Physiological Reports · doi:10.14814/phy2.14971 · Cited by 4 · see citing works
Impaired Glucose Tolerance in Primary Aldosteronism
Kotchen, T. A. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14765 · Cited by 4 · see citing works
Adimara, A., Prahasanti, K., Prahasanti, K., Airlangga, M. P., & Airlangga, M. P. (2021) · Jurnal Ilmiah Kedokteran Wijaya Kusuma · doi:10.30742/jikw.v10i2.1453 · Cited by 3 · see citing works
Sanyal, D., Mukhopadhyay, P., & Ghosh, S. K. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i18.3332 · Cited by 2 · see citing works
Xin, Y., Yin, Y., Zhu, L., Wang, Y., Wu, T., Xu, J., & Zang, L. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112160 · Cited by 2 · see citing works
Protective effects of ketogenic diet on aldosterone-induced atherosclerosis in ApoE−/− mice
Armani, A., Marzolla, V., Mammi, C., Vitiello, L., Bellucci, E., Feraco, A., Gorini, S., & Caprio, M. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02740-z · Cited by 2 · see citing works
Liang, J., Li, C., Zhang, Y., Ding, Y., Zhou, X., Xu, J., Wang, X., Han, Y., Wang, D., Shi, Y., et al. (2025) · BMC Genomics · doi:10.1186/s12864-025-12097-5 · Cited by 2 · see citing works
Aldosterone induced by chronic stress promotes pancreatic steatosis in young male rats
Pérez-Sánchez, E., Sánchez‐Solís, C. N., Morimoto, S., Corona‐Pérez, A., Martı́nez–Gómez, M., Rodríguez‐Antolín, J., Cuevas‐Romero, E., & Nicolás‐Toledo, L. (2026) · Cell and Tissue Research · doi:10.1007/s00441-025-04029-2 · Cited by 1 · see citing works
Unveiling the role of aldosterone in metabolic dysfunction–associated steatotic liver disease
Hernández‐Rubio, A., Julián, M. T., Valassi, E., Alonso, N., & Puig‐Domingo, M. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10056-3 · Cited by 1 · see citing works
Aldosterone and the mineralocorticoid receptor in insulin resistance and diabetes
Toloza, F. J. K., & Mendivil, C. O. (2017) · Alad · doi:10.24875/alad.m17000001
The Regulatory Effect of Renin-Angiotensin-Aldosterone System on Insulin Secretion *
Jia, Y., & Yang, B. (2013)
The Regulatory Effect of Renin-Angiotensin-Aldosterone System on Insulin Secretion
贾, 英. (2013) · Biophysics · doi:10.12677/jps.2013.13003
(2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283567080
Alamri, B. N., & Fantus, I. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-37275-9_11
Metabolic effects of aldosterone
Валерьевна, И. К., Mazurina, N. V., Platonova, N. M., & Troshina, E. A. (2024) · Obesity and metabolism · doi:10.14341/omet13040
- Authors
- Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J.
- Affiliations
- Vanderbilt University Medical Center (US)
- University of Tennessee Health Science Center (US)
- University of North Carolina at Chapel Hill (US)
- National Institutes of Health (US)
- VA Tennessee Valley Healthcare System (US)
- Corresponding author
- Luther, J. M.
- Venue
- Diabetologia
- Published
- 2011-04-26
- Volume
- 54
- Issue
- 8
- Pages
- 2152-2163
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3216479
- OpenAlex
- W1986937962
- Semantic Scholar
- a0c1e95c299c0afa3836d90ecaf36d72f7b3fc26
- Cited by
- 109
- References
- 52
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 3 · 2015: 9 · 2014: 4 · 2013: 10 · 2012: 11
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000666)
- Juvenile Diabetes Research Foundation International
- Vanderbilt University (DK59637, DK20593)
- National Institutes of Health (DK-59637, DK 20593, DK66636)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
- National Heart, Lung, and Blood Institute (R01HL060906, R01HL067308, HL060906, HL07738, HL067308)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK68854, K23DK081662, R01DK068764, DK089572, U01DK089572, DK69603, DK66636, DK59637, R21DK066636, R21DK068854, DK072473, DK 20593, U24DK059637, DK081662, R01DK069603, R33DK066636, U01DK072473, P30DK020593)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone, glucose-stimulated insulin secretion, aldosterone synthase deficiency, CYP11B2, mineralocorticoid receptor, reactive oxygen species, tempol, pancreatic beta cells, insulin sensitivity, impaired glucose tolerance, obesity, diabetes mellitus, sodium intake, renin-angiotensin system, islets
- MeSH terms
- Insulin Secretion, Aldosterone, Animals, Blood Glucose, Cell Line, Glucose, Insulin, Islets of Langerhans, Male, Mice, Inbred C57BL, Cytochrome P-450 CYP11B2, Insulin-Secreting Cells, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
